Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 19, 2026.

Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology - a systematic review

Robert Klopfleisch

BMC Veterinary Research · 2013 · Systematic review

doi:10.1186/1746-6148-9-123

Abstract

Background. Histopathology has initially been and is still used to diagnose infectious, degenerative or neoplastic diseases in humans or animals. In addition to qualitative diagnoses semiquantitative scoring of a lesion`s magnitude on an ordinal scale is a commonly demanded task for histopathologists. Multiparametric, semiquantitative scoring systems for mouse models histopathology are a common approach to handle these questions and to include histopathologic information in biomedical research.

Results. Inclusion criteria for scoring systems were a first description of a multiparametric, semiquantiative scoring systems which comprehensibly describe an approach to evaluate morphologic lesion. A comprehensive literature search using these criteria identified 153 originally designed semiquantitative scoring systems for the analysis of morphologic changes in mouse models covering almost all organs systems and a wide variety of disease models. Of these, colitis, experimental autoimmune encephalitis, lupus nephritis and collagen induced osteoarthritis colitis were the disease models with the largest number of different scoring systems. Closer analysis of the identified scoring systems revealed a lack of a rationale for the selection of the scoring parameters or a correlation between scoring parameter value and the magnitude of the clinical symptoms in most studies.

Conclusion. Although a decision for a particular scoring system is clearly dependent on the respective scientific question this review gives an overview on currently available systems and may therefore allow for a better choice for the respective project.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 19, 2026. Paragraph numbers are ours, so an answer can point at one.

Background

Histopathology has initially been and is still used today to diagnose infectious, degenerative or neoplastic diseases in humans or animals. These qualitative diagnoses are based on a sum of observable changes in the morphology of the analyzed tissue. The cognition of these changes is based on the pattern recognition of the observer and the comparison of these patterns with the known physiologic variation in tissue morphology in the respective species. Decades of experience in veterinary pathology show that this approach allows for reproducible qualitative diagnoses by the observer but can also be used for semiquantitative scoring of the lesions magnitude, i.e. on an ordinal scale for instance with a low, medium or high grade trichotomy which correlates with the clinical relevance of the lesions.

Absolute quantification of the lesions extent and severity is however difficult since two main problems hamper absolute quantification, i.e. on a rational scale with absolute values of 1, 2, 3 etc., using standard, non-automated histopathology. First, the detection method is not reliable enough. Despite intensive training and attempts to standardize nomenclature and the definition of lesions there are still unresolved issues in terms of interobserver variation which may be acceptable for qualitative and semiquantitative evaluation but not for absolute quantitation. Second, in most circumstances it is impossible to objectively justify the interval between two values, thus a read out of histopathologic scoring on a rational scale is impossible.

Image analysis by automated calculation of the tissue area affected or cells present per area have been introduced to overcome this problem. These approaches aim at a reliable and reproducible histopathology read out in a rational scale to allow proper statistical processing and at an exclusion of an observer bias. Image analysis approaches usually use one or only few two dimensional planar sections of the tissue of interest to measure three-dimensional objects. This two-dimensional approach thus may also lead to biased results. Stereology, which is based on systematic random sampling and estimates third dimensional information, has been developed to avoid this bias. It can therefore be seen as the most sophisticated method for the quantification of histologic information. It is however by comparison a laborious and complex method which is established in only few laboratories.

Semiquantitative scoring systems are therefore still the most widely used methods to include histopathologic information in biomedical research. These scoring systems usually include multiple parameters which are separately quantified on an ordinal scale and finally combined in a total score. Average scores of the different experimental groups can then be compared by non-parametric statistical tests. The selection of the parameters should be based on the scientific hypothesis or question together with the current knowledge on the morphologic outcome of the investigated disease model. It may therefore be useful to design individual scoring system for each study which in the best possible way answers the particular scientific question. Standard scoring systems for specific disease models on the other hand allow for the comparison of the results of different studies.

Several standard scoring systems for different mouse models have been introduced or emerged in the past 20 years. Histopathologists are therefore repeatedly requested by cooperating scientists to evaluate the outcome of animal studies using standard scoring systems or to elaborate project specific scoring systems. The present review is intended to give a comprehensive overview on the currently most commonly used multiparametric, semiquantitative scoring systems for mouse model histopathology.

Scoring systems for murine intestinal disease models

Eighteen original scoring systems for colitis models could be identified. Most of these scoring systems were designed for dextran sodium sulfate (DSS)-induced colitis models but 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis and several models of immunopathologic colitis were also used to establish scoring systems (Table 1, Figure 1). Eight scoring systems for DSS-induced colitis fulfilled all required parameters and were included in this review. Generally, all of the paper with original DSS colitis scoring systems had a high citation rate but the scoring system described by Cooper is one of the earliest system with the highest citation number up to date and can therefore be seen as a prototype for DSS-colitis scoring. It separates the colon into three segments which are then scored by the parameters of crypt loss, inflammation and affected area. Although later studies refined and increased the number of histopathologic parameters the value of this initial study is the separation of the colon in three segments and the sophisticated approach to the establishment of the scoring system. Remarkably, parameters in this study were chosen and tested according to their correlation with the clinical symptoms of the mice. This is contrast to the vast majority of scoring systems presented in this review, which only rarely stated the rational for choosing the included parameters and did not perform a correlation with the clinical symptoms.

When comparing all original colitis models it becomes obvious that a wide variety of appellation for the most common parameters inflammation, crypt and surface epithelial damage were used (Table 1). These differences in the nomenclature make it however difficult to directly compare the different scoring systems. Less often used parameters in the colitis scoring systems were goblet cell loss, regeneration, muscular and epithelial hyperplasia, edema and the separation between acute and chronic inflammation. In some cases these singularities of the respective scoring system seem to be dependent on the objectives of the study while in most cases the rationale for selection of the parameters was not given.

The number of identified scoring systems for small intestinal disease was significantly lower than for colitis models and had on average lesser citations (Table 1). Two independent scoring systems were identified for intestinal ischemia which include the comprehensible parameters of hyperemia and hemorrhage as well as inflammation and epithelial damage and in the case of the higher cited publication by Park et al. several other more sophisticated parameters. Only two scoring systems for small intestinal enteritis were detected which both included villous morphology, epithelial damage and inflammation as the main features (Table 1). Surprisingly, only one semiquantitative scoring system for gastritis was identified. Wang et al. scored the severity of Helicobacter-induced gastritis in a uniparametric scoring of five gastric areas. For the sake of completeness this studies was included in this review although it did not fulfill the criterion of multiple parameters.

Scoring systems for murine osteoarthritis models

Seventeen original semiquantitative, multiparametric scoring systems were identified for murine osteoarthritis models (Table 2). Three of these, designated as osteoarthritis in Table 2, are scoring systems for human idiopathic arthritis and were transferred to the murine model to allow for comparisons of the model with the human disease. Of these the the score developed by Mankin et al. has by far the highest citation number which is most probably influenced by its common application in the description of human osteoarthritic lesion. The majority of mouse specific systems were established in collagen-induced models while models of instability-induced or bacterial arthritis models were only rarely used. Of these, the scoring system by William et al. had the highest citation number. Twelve of the thirteen osteoarthritis scoring systems include an evaluation of cartilage damage, nine included an infiltration parameter, seven included changes in perichondral bone structure and six studies evaluated the extend of synovial infiltration (Table 2). Other parameters like tidemark integrity, proteoglycan content of the cartilage, pannus formation or synovial hyperplasia were used only in the minority or single scoring systems. Again, in most of these descriptions of original scoring systems no rational for inclusion of the respective parameters is given but their usefulness can be comprehended by reflecting the general pathogenesis of osteoarthritis.

Scoring systems for murine renal disease models

Fourteen original multiparametric, semiquantitative scoring systems for murine models of renal diseases fulfilled the required criteria for inclusion in this review (Table 3). Scoring systems for murine Lupus erythematous models were the dominant model in the category of renal disease models with four appearances. Austin et al. published the lupus nephritis score with the highest citation number. It uses a complex scoring system with 10 parameters and a scale width of four and five respectively and was thus more sophisticated than the other scoring systems which used only four different parameters.

Glomerular cellularity and proliferation were the terms most commonly used in all renal scoring systems except one scoring system for obstructive nephropathy model. In addition, one half of the systems included tubulointerstitial infiltration and fibrosis in the scoring system.

Scoring systems for murine models of neurologic disease

Twenty-two original scoring systems for murine models of central nervous system (CNS) disease were identified (Table 4). Scoring systems for experimental autoimmune encephalomyelitis (EAE) and stroke clearly dominated results. Due to the wide variety of diseases covered by the system the selection of parameters to be analyzed also had a wide variation and was clearly dependent on the pathophysiology of the disease. But again, the rationale for inclusion of parameters was not consistently given.

A striking feature of CNS disease scoring systems was the relatively low number of ordinal scales for parameter´s magnitudes and the common inclusion of multiple anatomical sites into the scoring system (Table 4). This discrepancy is not addressed in the respective publications but may be based on the anatomical diversity of the CNS. Furthermore, the inclusion of absolute values like lesions/mm2 occurred significantly more often in CNS disease scoring than for other organs although this is not comprehensible in each case. Only one scoring system occurred for a peripheral nerve system disease which has been developed to evaluate peripheral nerve ischemia in a relatively simple two-tier system with a zero to four-scale.

Scoring systems for murine models of pulmonary diseases

Fourteen original semiquantitative, multiparametric scoring systems were identified for pulmonary diseases (Table 5). Of these pulmonary fibrosis and pulmonary inflammation were diseases with the highest number scoring systems and citations. For instance, the scoring system developed by Ashcroft, which is a relatively simple multiparametric but single scaled system, is commonly used for the evaluation of lung fibrosis. Three scoring systems were developed for models of general acute lung inflammation (Table 5). They used the parameters of edema and anatomical site specific inflammation as parameters to evaluate the relative amount of inflammatory response. Similar parameters in a wide variety of combinations were used to develop scoring systems for diverse infectious pneumonia models. This variation is again in most cases not based on reasonable argument for the inclusion of a certain parameter in a certain model and therefore not in all cases clearly associated with the supposed pathogen-associated pathogenesis of the respective pneumonia.

Scoring systems for myocardial, vascular and muscular disease models

Three original scoring systems for the evaluation of viral myocarditis were identified. All of them included the evaluation of the parameters of myocardial necrosis and inflammation (Table 6). In addition, two of them also included calcification as a parameter while fibrosis and Evans blue-staining as a marker of myofiber damage were used as a parameter of myocardial disease only once.

Three semiquantitative scoring systems for the most important human vascular diseases were identified: atherosclerosis, aneurysms and vasculitis (Table 6). They all cover several aspects of the pathogenesis and pathophysiology of the diseases but have been generally rarely cited yet. The aneurysm scoring system grades the severity of the disease by the extent of medial and adventitial lesion together with the general size of the lesion. The atherosclerosis scoring systems uses a 5-tier system with a 0–1 scale width, whereas the vasculitis score uses the parameters infiltration, elastic lamina destruction and intimal thickening, thus indicating that the system may only be useful for evaluation of larger vessel types.

Two scoring systems for muscular disease models were identified (Table 6). One recently published scoring system evaluated the extent of Trypanosoma-induced myositis while the other scoring system was developed to quantify the extent of ischemia-induced muscle necrosis by the parameters necrosis, infiltration and hemorrhage.

Scoring systems for hepatic and pancreatic diseases

Ten original scoring systems for chronic hepatitis have been developed or used for the quantification chronic hepatic disease (Table 7). The scoring systems by Ishak and Knodell are both highly cited scoring systems and cover almost all possible histomorphologic changes in chronically inflamed livers. The two identified scoring systems for acute hepatitis quantify lesions by grading the extent of inflammation and necrosis, similar to the Ishak system for chronic hepatitis.

Five scoring systems for the evaluation of acute pancreatitis have been identified (Table 7). The first and most commonly cited scoring system was published by Schmidt et al.. It uses the five parameters edema, necrosis, inflammation, hemorrhage and fat necrosis to score the extent of pancreatic lesions. All four later developed scoring systems only marginally modified the parameters by omitting a single parameter or including vacuolization as an additional marker (Table 7). In addition, one multiparametric but several uniparametric (data not shown) scoring systems were identified for the quantification of insulitis in mice models. The scoring system by Papaccio et al. uses islet infiltration, atrophy and destruction as parameters for the evaluation of Isle of Langerhans inflammation.

Scoring systems for skin and ocular diseases and miscellaneous disease models

Murine psoriasis models are the only skin disease model with more than one identified scoring system (Table 8). Both scoring systems offer a wide variety of parameters for the evaluation of epidermal and dermal changes in models of this relevant human disease. In addition, scoring systems for dermal sclerosis, burn scars, atopic dermatitis and epithelial irritation were identified (Table 8).

Five original scoring systems for the evaluation of ocular diseases were identified. Two of these systems use only one parameter for the evaluation of autoimmune and endotoxin uveitis. For the sake of completeness these scoring systems are also displayed in Table 8, although they do not fulfill requirements for inclusion. Furthermore, the identified scoring system for diabetic retinopathy uses two parameters evaluated in absolute numbers of leukocytes per area.

Three scoring systems for the evaluation of abdominal adhesions after traumatic or toxic irritation of the peritoneum could be identified. Interestingly, not all scoring systems for abdominal adhesion use fibrosis as a parameter for the grading of the adhesions. Finally, very helpful scoring systems for the evaluation of embryonic development and wound healing could be identified (Table 8).

Scoring systems for systemic diseases and transplant rejection

Three original scoring systems analyzing lesions associated with graft-versus-host disease (GvHD) are available (Table 9). The most cited scoring system by Hill et al. exclusively covers intestinal lesions associated with GvHD. This system allows a very thorough analysis of intestinal lesion using a wide variety of parameters in the small and large intestine. The other two systems also cover intestinal lesions but provide additional parameters for the analysis of hepatic or hepatic and skin lesions.

Three original scoring systems have been developed for the analysis lesions associated with hemorrhagic shock (Table 9). The scoring system with the highest citation number only focusses on the pulmonary lesion and offers a variety of parameters for the evaluation of shock-induced lesions in the lung. The other two scoring system also include parameters for lung evaluation but both offer additional parameters for the quantification of intestinal changes or in one case offer scoring systems for renal and hepatic lesions associated with hemorrhagic shock.

The identified scoring system for immunotoxicity of toxins more or less demands the analysis of all immune organs but gives a good guideline in terms of the nomenclature of morphologic changes associated with the toxin application (Table 9).

Finally, the three scoring systems which have been used for murine transplant rejection models have consistently been developed for the evaluation of tissues from human patients (Table 9). They are all used in mouse models unmodified to allow for better conclusions from the mouse models for the situation in the human patient.

Discussion

Extensive research of the literature identified 146 originally designed semiquantitative, multiparametric scoring systems for the histopathology of mouse models. These scoring systems cover almost all organs systems and a wide variety of disease models. Colitis and especially ulcerative colitis was the disease model with the largest number of different scoring system closely followed by experimental autoimmune encephalitis (EAE), lupus nephritis and collagen induced osteoarthritis.

The number of citations for the publication including the scoring system varied between few citations and up to 2176. The citation number clearly reflects the value of the scientific work shown in the papers and thus also indirectly reflects the quality of the included scoring systems. In some cases there is even clear evidence that the high citation number is directly based on the “gold” standard character of the scoring system and its regular use in mouse models or human tissues, for instance the score from Mankin et al. for osteoarthritis evaluation and the scores developed by Knodell and Ishak et al. for chronic hepatitis or the score by Cooper et al. for DSS-colitis. Nevertheless, after careful analysis of the publication it also became obvious that scoring systems in publications with a small number of citation also proofed to be of expedience for certain scientific question.

Assuming that the main function of scoring systems is the analysis of the influences of experimental factors on the microscopical tissue morphology the selected parameters should be consciously chosen to be able to reflect the potential changes. The lack of a rationale for the selection of the parameters was therefore an emerging and surprising finding during the literature search for this study. Although the selection of parameters in most scoring systems is comprehensibly based on the common knowledge on the pathogenesis of the disease modeled in the mouse, there is only rarely a clear statement or a line of argument for choosing a parameter. Even less often the correlation between scoring parameter value and the magnitude of the clinical symptoms or the differences in the extent of the experimental factor is given as for instance in the excellent study of Cooper et al.. This lack is most probably due to the time-consuming work involved, but it may however tremendously increase the value and the scientific merit of the scoring system.

Conclusion

In summary, a final judgment of the quality and the usefulness of the scoring systems presented was not an aim of this study and is after all most probably not possible since the value of a scoring system clearly depends on the scientific question, the underlying hypothesis, the model characteristics and the pathogenesis of the disease. This review may however give an overview on currently available scoring systems and may therefore allow for a better choice for the respective project.

Selection of scoring systems

The systematic review was prepared according to the PRISMA guidelines. All items were considered and can be viewed in Additional file 1. Scoring systems were identified by a comprehensive Pubmed search (http://www.ncbi.nlm.nih.gov/pubmed/) using a combination of the search terms “mouse”, “score”, “histopathology”. This led to the identification of 1479 publication by October 30, 2012 (Figure 1). Full text versions of all publications were obtained and analyzed for the description of multiparametric, semiquantitative, scoring systems for the histopathology of mouse models. Inclusion of a mouse scoring system in this overview was based on the fulfillment of six parameters.

First, the scoring system had to be based on the semiquantitative evaluation of histopathologic changes in murine tissues. Thus, approaches using digital image analysis for absolute quantification of lesion area, cell number or immunohistochemical signals or scoring systems with dominance of immunohistochemical markers as evaluation parameters were not included.

Second, only scoring systems evaluating more than one histomorphologic parameter were included in the review. Nevertheless, scoring systems with high citation numbers which combined several parameters in a uniparametric score were also included. For instance, if a highly cited scoring system integrated the presence and extent of crypt abscesses, epithelial sloughing and submucosal infiltration into a single score of 0 to 4 the study was also included.

Third, the scoring approach had to be comprehensibly described to allow for reproduction by the reader.

Fourth, the scoring system had to be originally designed for the presented study without citation of former publications. If former publications were cited as the source of the scoring system, the string of citations was followed back to the study originally describing the scoring systems. If scorings systems were not referenced to older studies but similar approaches were detected in earlier publication, only the older study was included in this review.

Fifth, the scoring systems were generally grouped by the organ affected and analyzed. Systemic diseases and transplantation models were included in separate groups. If the number of identified scoring systems for a specific disease model exceeded ten, only the then most cited scoring systems were included in this review.

Citation number was obtained using Thomson Reuters Web Science© (http://apps.webofknowledge.com).

Competing interests

The author declares that he has no competing interests.

Author’s contributions

RK had the idea of the project, performed the internet search, the data analysis and wrote the abstract.

References 157

  1. 1.

    Renshaw AA Gould EW Measuring errors in surgical pathology in real-life practice - Defining what does and does not matterAm J Clin Pathol2007 1271144152

    Not in our library10.1309/5kf89p63f4f6euhb

  2. 2.

    Riber-Hansen R Vainer B Steiniche T Digital image analysis: a review of reproducibility, stability and basic requirements for optimal resultsAPMIS2012 1204276289

    Not in our library10.1111/j.1600-0463.2011.02854.x

  3. 3.

    Boyce RW Dorph-Petersen KA Lyck L Gundersen HJG Design-based Stereology: Introduction to Basic Concepts and Practical Approaches for Estimation of Cell NumberToxicol Pathol2010 38710111025

    Not in our library10.1177/0192623310385140

  4. 4.

    Cooper HS Murthy SNS Shah RS Sedergran DJ Clinicopathological Study of Dextran Sulfate Sodium Experimental Murine ColitisLab Invest1993 692238249

    Not in our library

  5. 5.

    Dieleman LA Ridwan BU Tennyson GS Beagley KW Bucy RP Elson CO Dextran Sulfate Sodium-Induced Colitis Occurs in Severe Combined Immunodeficient MiceGastroenterology1994 107616431652

    Not in our library10.1016/0016-5085(94)90803-6

  6. 6.

    Dieleman LA Palmen MJHJ Akol H Bloemena E Pena AS Meuwissen SGM van Rees EP Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokinesClin Exp Immunol1998 1143385391

    Not in our library10.1046/j.1365-2249.1998.00728.x

  7. 7.

    Murthy SNS Cooper HS Shim H Shah RS Ibrahim SA Sedergran DJ Treatment of Dextran Sulfate Sodium-Induced Murine Colitis by Intracolonic CyclosporineDigest Dis Sci1993 38917221734

    Not in our library10.1007/bf01303184

  8. 8.

    Mahler M Bristol IJ Leiter EH Workman AE Birkenmeier EH Elson CO Sundberg JP Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitisAm J Physiol-Gastr L1998 2743G544G551

    Not in our library10.1152/ajpgi.1998.274.3.g544

  9. 9.

    Hudert CA Weylandt KH Lu Y Wang JD Hong S Dignass A Serhan CN Kang JX Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitisP Natl Acad Sci USA2006 103301127611281

    Not in our library10.1073/pnas.0601280103

  10. 10.

    Obermeier F Kojouharoff G Hans W Scholmerich J Gross V Falk W Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in miceClin Exp Immunol1999 1162238245

    Not in our library10.1046/j.1365-2249.1999.00878.x

  11. 11.

    Hartmann G Bidlingmaier C Siegmund B Albrich S Schulze J Tschoep K Eigler A Lehr HA Endres S Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in miceJ Pharmacol Exp Ther2000 29212230

    Not in our library

  12. 12.

    Neurath MF Fuss I Kelsall BL Stuber E Strober W Antibodies to Interleukin-12 Abrogate Established Experimental Colitis in MiceJ Exp Med1995 182512811290

    Not in our library10.1084/jem.182.5.1281

  13. 13.

    Dohi T Fujihashi K Rennert PD Iwatani K Kiyono H McGhee JR Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responsesJ Exp Med1999 189811691179

    Not in our library10.1084/jem.189.8.1169

  14. 14.

    Appleyard CB Wallace JL Reactivation of Hapten-Induced Colitis and Its Prevention by Antiinflammatory DrugsAm J Physiol-Gastr L1995 2691G119G125

    Not in our library10.1152/ajpgi.1995.269.1.g119

  15. 15.

    Macpherson BR Pfeiffer CJ Experimental Production of Diffuse Colitis in RatsDigestion1978 172135150

    Not in our library10.1159/000198104

  16. 16.

    ten Hove T van den Blink B Pronk I Drillenburg P Peppelenbosch MP van Deventer SJH Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitisGut2002 504507512

    Not in our library10.1136/gut.50.4.507

  17. 17.

    Rath HC Herfarth HH Ikeda JS Grenther WB Hamm TE Balish E Taurog JD Hammer RE Wilson KH Sartor RB Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta(2) microglobulin transgenic ratsJ Clin Invest1996 984945953

    Not in our library10.1172/jci118878

  18. 18.

    Madsen KL Doyle JS Jewell LD Tavernini MM Fedorak RN Lactobacillus species prevents colitis in interleukin 10 gene-deficient miceGastroenterology1999 116511071114

    Not in our library10.1016/s0016-5085(99)70013-2

  19. 19.

    Berg DJ Davidson N Kuhn R Muller W Menon S Holland G ThompsonSnipes L Leach MW Rennick D Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responsesJ Clin Invest1996 98410101020

    Not in our library10.1172/jci118861

  20. 20.

    Burns RC Rivera-Nieves J Moskaluk CA Matsumoto S Cominelli F Ley K Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in miceGastroenterology2001 121614281436

    Not in our library10.1053/gast.2001.29568

  21. 21.

    Houpt ER Glembocki DJ Obrig TG Moskaluk CA Lockhart LA Wright RL Seaner RM Keepers TF Wilkins TD Petri WA The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4(+) T cellsJ Immunol2002 169844964503

    Not in our library10.4049/jimmunol.169.8.4496

  22. 22.

    Pothoulakis C Castagliuolo I Lamont JT Jaffer A Okeane JC Snider RM Leeman SE Cp-96,345, a Substance-P Antagonist, Inhibits Rat Intestinal Responses to Clostridium-Difficile Toxin-a but Not Cholera-ToxinP Natl Acad Sci USA1994 913947951

    Not in our library10.1073/pnas.91.3.947

  23. 23.

    Park PO Haglund U Bulkley GB Falt K The Sequence of Development of Intestinal Tissue-Injury after Strangulation Ischemia and ReperfusionSurgery1990 1075574580

    Not in our library

  24. 24.

    Lane JS Todd KE Lewis MPN Gloor B Ashley SW Reber HA McFadden DW Chandler CF Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusionSurgery1997 1222288294

    Not in our library10.1016/s0039-6060(97)90020-9

  25. 25.

    de Koning BAE van Dieren JM Lindenbergh-Kortleve DJ van der Sluis M Matsumoto T Yamaguchi K Einerhand AW Samsom JN Pieters R Nieuwenhuis EES Contributions of mucosal immune cells to methotrexate-induced mucositisInt Immunol2006 186941949

    Not in our library10.1093/intimm/dxl030

  26. 26.

    Stewart-Tull DES Coote JG Thompson DH Candlish D Wardlaw AC Candlish A Virulence spectra of typed strains of Campylobacter jejuni from different sources: a blinded in vivo studyJ Med Microbiol2009 585546553

    Not in our library10.1099/jmm.0.005611-0

  27. 27.

    Wang X Sturegard E Rupar R Nilsson HO Aleljung PA Carlen B Willen R Wadstrom T Infection of BALB/c a mice by spiral and coccoid forms of Helicobacter pyloriJ Med Microbiol1997 468657663

    Not in our library10.1099/00222615-46-8-657

  28. 28.

    Mankin HJ Dorfman H Lippiell L Zarins A Biochemical and Metabolic Abnormalities in Articular Cartilage from Osteo-Arthritic Human Hips.2. Correlation of Morphology with Biochemical and Metabolic DataJ Bone Joint Surg Am1971 533523

    Not in our library

  29. 29.

    Williams RO Feldmann M Maini RN Antitumor Necrosis Factor Ameliorates Joint Disease in Murine Collagen-Induced ArthritisP Natl Acad Sci USA1992 892097849788

    Not in our library10.1073/pnas.89.20.9784

  30. 30.

    Pritzker KPH Gay S Jimenez SA Ostergaard K Pelletier JP Revell PA Salter D van den Berg WB Osteoarthritis cartilage histopathology: grading and stagingOsteoarthr Cartilage2006 1411329

    Not in our library10.1016/j.joca.2005.07.014

  31. 31.

    Krenn V Morawietz L Burmester GR Kinne RW Mueller-Ladner U Muller B Haupl T Synovitis score: discrimination between chronic low-grade and high-grade synovitisHistopathology2006 494358364

    Not in our library10.1111/j.1365-2559.2006.02508.x

  32. 32.

    Joosten LAB Helsen MMA Saxne T van de Loo FAJ Heinegard D van den Berg WB IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammationJ Immunol1999 163950495055

    Not in our library

  33. 33.

    Delgado M Abad C Martinez C Laceta J Gomariz RP Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the diseaseNat Med2001 75563568

    Not in our library10.1038/87887

  34. 34.

    Adkison AM Raptis SZ Kelley DG Pham CTN Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritisJ Clin Invest2002 1093363371

    Not in our library10.1172/jci13462

  35. 35.

    Bendele A McComb J Gould T McAbee T Sennello G Chlipala E Guy M Animal models of arthritis: Relevance to human diseaseToxicol Pathol1999 271134142

    Not in our library10.1177/019262339902700125

  36. 36.

    Taniguchi K Kohsaka H Inoue N Terada Y Ito H Hirokawa K Miyasaka N Induction of the p16(INK4a) senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritisNat Med1999 57760767

    Not in our library10.1038/10480

  37. 37.

    Helyes Z Szabo A Nemeth J Jakab B Pinter E Banvolgyi A Kereskai L Keri G Szolcsanyi J Antiinflammatory and analgesic effects of somatostatin released from capsaicin-sensitive sensory nerve terminals in a Freund's adjuvant-induced chronic arthritis model in the ratArthritis Rheum2004 50516771685

    Not in our library10.1002/art.20184

  38. 38.
  39. 39.

    Rudolphi K Gerwin N Verzijl N van der Kraan P van den Berg W Pralnacasan, an inhibitor of interleukin-1 beta converting enzyme, reduces joint damage in two murine models of osteoarthritisOsteoarthr Cartilage2003 1110738746

    Not in our library10.1016/s1063-4584(03)00153-5

  40. 40.

    Kamekura S Hoshi K Shimoaka T Chung U Chikuda H Yamada T Uchida M Ogata N Seichi A Nakamura K Osteoarthritis development in novel experimental mouse models induced by knee joint instabilityOsteoarthr Cartilage2005 137632641

    Not in our library10.1016/j.joca.2005.03.004

All 157 references

Cited by papers we hold 3

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.